Stay updated on Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The record now presents details of the CaboPen phase 2 study of cabozantinib for advanced penile squamous cell carcinoma, including eligibility, treatment, outcomes, contacts, and study dates.
    Difference
    57%
    Check dated 2026-11-09T14:57:11.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-02T16:25:48.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A banner announces an NIH-wide transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:45:05.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T21:44:54.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T04:15:02.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content with an error page. This prevents viewing the trial details and related information that the page is meant to provide.
    Difference
    19%
    Check dated 2026-09-21T22:14:10.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Penile Squamous Cell Carcinoma Clinical Trial page.